Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation–related mild ischemic stroke: a randomized clinical trial
Importance In atrial fibrillation (AF)–related acute ischemic stroke, the optimal oral
anticoagulation strategy remains unclear. Objective To test whether rivaroxaban or warfarin
sodium is safer and more effective for preventing early recurrent stroke in patients with AF-
related acute ischemic stroke. Design, Setting, and Participants A randomized, multicenter,
open-label, blinded end point evaluation, comparative phase 2 trial was conducted from
April 28, 2014, to December 7, 2015, at 14 academic medical centers in South Korea among …
anticoagulation strategy remains unclear. Objective To test whether rivaroxaban or warfarin
sodium is safer and more effective for preventing early recurrent stroke in patients with AF-
related acute ischemic stroke. Design, Setting, and Participants A randomized, multicenter,
open-label, blinded end point evaluation, comparative phase 2 trial was conducted from
April 28, 2014, to December 7, 2015, at 14 academic medical centers in South Korea among …
以上显示的是最相近的搜索结果。 查看全部搜索结果